Alkylation of DNA

Alkylation of DNA refers broadly to the covalent attachment (“alkylation”) of one or more alkyl groups onto nucleophilic atoms within the nitrogenous bases or phosphate backbone within the double helix structure. This chemical modification can occur at multiple positions on all four bases—most notably at N3/N7 adenine and guanine; O6/N7 guanine; N3/O2/O4 thymine; N3/O2/N4 cytosine—as well as on the phosphate backbone itself. Sources include endogenous metabolic byproducts, environmental toxins such as nitrosamines from tobacco smoke/grilled foods/pollutants, and most importantly clinically administered chemotherapeutic agents known collectively as “alkylating agents.” These modifications disrupt normal base pairing during replication/transcription—causing stalling/mutations/cell death if unrepaired—and trigger complex cellular responses including activation/recruitment/upregulation/downregulation among various components within base excision/nucleotide excision/mismatch repair systems. While exploited therapeutically against rapidly dividing tumor cells using drugs like temozolomide/chlorambucil/carmustine/etc., off-target effects limit clinical utility due both to acute toxicities and increased risk for secondary malignancies over time.[1][2][5]

Other names

DNA alkylationAlkylated DNAAlkylating damage to DNA

For drugs inducing this process: Covalent transfer of alkyl groups onto nucleophilic sites on DNA bases (e.g., N7 guanine, O6 guanine), leading to mispairing during replication and/or strand breaks[1][5]. Induction of cytotoxicity via formation of cross-links or abasic sites when repair fails. For cellular response: Activation of base excision repair pathways via glycosylases like AAG/MPG.